<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35320461</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-6903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurochemical research</Title>
          <ISOAbbreviation>Neurochem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Altered Topographic Distribution and Enhanced Neuronal Expression of Adenosine-Metabolizing Enzymes in Rat Hippocampus and Cortex from Early to late Adulthood.</ArticleTitle>
        <Pagination>
          <StartPage>1637</StartPage>
          <EndPage>1650</EndPage>
          <MedlinePgn>1637-1650</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-022-03557-5</ELocationID>
        <Abstract>
          <AbstractText>The present study demonstrates altered topographic distribution and enhanced neuronal expression of major adenosine-metabolizing enzymes, i.e. ecto-5'-nucleotidase (eN) and tissue non-specific alkaline phosphatase (TNAP), as well as adenosine receptor subtype A<sub>2A</sub> in the hippocampus and cortex of male rats from early to late adulthood (3, 6, 12 and 15 months old males). The significant effect of age was demonstrated for the increase in the activity and the protein expression of eN and TNAP. At 15-m, enzyme histochemistry demonstrated enhanced expression of eN in synapse-rich hippocampal and cortical layers, whereas the upsurge of TNAP was observed in the hippocampal and cortical neuropil, rather than in cells and layers where two enzymes mostly reside in 3-m old brain. Furthermore, a dichotomy in A<sub>1</sub>R and A<sub>2A</sub>R expression was demonstrated in the cortex and hippocampus from early to late adulthood. Specifically, a decrease in A<sub>1</sub>R and enhancement of A<sub>2A</sub>R expression were demonstrated by immunohistochemistry, the latter being almost exclusively localized in hippocampal pyramidal and cortical superficial cell layers. We did not observe any glial upregulation of A<sub>2A</sub>R, which was common for both advanced age and chronic neurodegeneration. Taken together, the results imply that the adaptative changes in adenosine signaling occurring in neuronal elements early in life may be responsible for the later prominent glial enhancement in A<sub>2A</sub>R-mediated adenosine signaling, and neuroinflammation and neurodegeneration, which are the hallmarks of both advanced age and age-associated neurodegenerative diseases.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dragic</LastName>
            <ForeName>Milorad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4855-6131</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stekic</LastName>
            <ForeName>Andjela</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2353-2937</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeljkovic</LastName>
            <ForeName>Milica</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5608-4384</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaric Kontic</LastName>
            <ForeName>Marina</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-1635-9766</Identifier>
            <AffiliationInfo>
              <Affiliation>Department for Molecular biology and Endocrinology, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mihajlovic</LastName>
            <ForeName>Katarina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adzic</LastName>
            <ForeName>Marija</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4018-0758</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grkovic</LastName>
            <ForeName>Ivana</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0003-4476-7871</Identifier>
            <AffiliationInfo>
              <Affiliation>Department for Molecular biology and Endocrinology, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nedeljkovic</LastName>
            <ForeName>Nadezda</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-3046-0983</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia. nnedel@bio.bg.ac.rs.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurochem Res</MedlineTA>
        <NlmUniqueID>7613461</NlmUniqueID>
        <ISSNLinking>0364-3190</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043705">Receptor, Adenosine A2A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.5</RegistryNumber>
          <NameOfSubstance UI="D015720">5'-Nucleotidase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>K72T3FS567</RegistryNumber>
          <NameOfSubstance UI="D000241">Adenosine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015720" MajorTopicYN="Y">5'-Nucleotidase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000241" MajorTopicYN="Y">Adenosine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043705" MajorTopicYN="N">Receptor, Adenosine A2A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">A2AR</Keyword>
        <Keyword MajorTopicYN="N">Adenosine deaminase (ADA)</Keyword>
        <Keyword MajorTopicYN="N">Tissue non-specific alkaline phosphatase (TNAP)</Keyword>
        <Keyword MajorTopicYN="N">ecto-5ʹ-nucleotidase/CD73</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>17</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35320461</ArticleId>
        <ArticleId IdType="doi">10.1007/s11064-022-03557-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s11064-022-03557-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jin K (2010) “Modern Biological Theories of Aging.,” Aging and disease, vol. 1, no. 2, pp. 72–74, Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Mattson MP, Arumugam TV (Jun. 2018) “Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. ” Cell metabolism 27(6):1176–1199. https://doi.org/10.1016/j.cmet.2018.05.011</Citation>
        </Reference>
        <Reference>
          <Citation>Drayer BP (Mar. 1988) “Imaging of the aging brain. Part I. Normal findings. ” Radiol 166(3):785–796. https://doi.org/10.1148/radiology.166.3.3277247</Citation>
        </Reference>
        <Reference>
          <Citation>Deary IJ et al (2009) Age-associated cognitive decline. ” Br Med Bull 92:135–152. https://doi.org/10.1093/bmb/ldp033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bmb/ldp033</ArticleId>
            <ArticleId IdType="pubmed">19776035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimohama S et al (1998) “Differential expression of rat brain synaptic proteins in development and aging.,” Biochemical and biophysical research communications, vol. 251, no. 1, pp. 394–398, https://doi.org/10.1006/bbrc.1998.9480</Citation>
        </Reference>
        <Reference>
          <Citation>Pannese E (2011) “Morphological changes in nerve cells during normal aging.,” Brain structure &amp; function, vol. 216, no. 2, pp. 85–89, Jun. https://doi.org/10.1007/s00429-011-0308-y</Citation>
        </Reference>
        <Reference>
          <Citation>Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ (Jan. 2018) The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain. ” Cell reports 22(1):269–285. https://doi.org/10.1016/j.celrep.2017.12.039</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA (Dec. 2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139(6):1019–1055. https://doi.org/10.1111/jnc.13724</Citation>
        </Reference>
        <Reference>
          <Citation>Kovács Z, Juhász G, Palkovits M, Dobolyi A, Kékesi KA (2011) “Area, age and gender dependence of the nucleoside system in the brain: a review of current literature. ” Curr Top Med Chem 11(8):1012–1033. https://doi.org/10.2174/156802611795347636</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156802611795347636</ArticleId>
            <ArticleId IdType="pubmed">21401498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fredholm BB, Chern Y, Franco R, Sitkovsky M (Dec. 2007) Aspects of the general biology of adenosine A2A signaling. ” Progress in neurobiology 83(5):263–276. https://doi.org/10.1016/j.pneurobio.2007.07.005</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA (Jan. 2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. ” Neurochemistry international 52:1–2. https://doi.org/10.1016/j.neuint.2007.06.026</Citation>
        </Reference>
        <Reference>
          <Citation>Pazzagli M, Corsi C, Fratti S, Pedata F, Pepeu G (Jun. 1995) Regulation of extracellular adenosine levels in the striatum of aging rats. ” Brain research 684(1):103–106. https://doi.org/10.1016/0006-8993(95)00471-2</Citation>
        </Reference>
        <Reference>
          <Citation>Rex CS, Kramár EA, Colgin LL, Lin B, Gall CM, Lynch G (2005) “Long-term potentiation is impaired in middle-aged rats: regional specificity and reversal by adenosine receptor antagonists.,” The Journal of neuroscience: the official journal of the Society for Neuroscience, vol. 25, no. 25, pp. 5956–5966, Jun. https://doi.org/10.1523/JNEUROSCI.0880-05.2005</Citation>
        </Reference>
        <Reference>
          <Citation>Mackiewicz M et al (Feb. 2006) Age-related changes in adenosine metabolic enzymes in sleep/wake regulatory areas of the brain. ” Neurobiol aging 27(2):351–360. https://doi.org/10.1016/j.neurobiolaging.2005.01.015</Citation>
        </Reference>
        <Reference>
          <Citation>Gharib A, Sarda N, Chabannes B, Cronenberger L, Pacheco H (Mar. 1982) “The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. ” J neurochemistry 38(3):810–815. https://doi.org/10.1111/j.1471-4159.1982.tb08702.x</Citation>
        </Reference>
        <Reference>
          <Citation>Murillo-Rodriguez E, Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ (2004) The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats. ” Neurosci 123(2):361–370. https://doi.org/10.1016/j.neuroscience.2003.09.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2003.09.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovács Z et al (Apr. 2010) “Gender- and age-dependent changes in nucleoside levels in the cerebral cortex and white matter of the human brain. ” Brain research bulletin 81(6):579–584. https://doi.org/10.1016/j.brainresbull.2009.10.010</Citation>
        </Reference>
        <Reference>
          <Citation>Chu S et al (Jan. 2013) Regulation of adenosine levels during cerebral ischemia. ” Acta pharmacologica Sinica 34(1):60–66. https://doi.org/10.1038/aps.2012.127</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmermann H, Zebisch M, Sträter N (Sep. 2012) “Cellular function and molecular structure of ecto-nucleotidases. ” Purinergic signalling 8(3):437–502. https://doi.org/10.1007/s11302-012-9309-4</Citation>
        </Reference>
        <Reference>
          <Citation>Street SE et al (Jul. 2013) “Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 33:11314–11322. https://doi.org/10.1523/JNEUROSCI.0133-13.2013</Citation>
        </Reference>
        <Reference>
          <Citation>Latini S, Pedata F (Nov. 2001) “Adenosine in the central nervous system: release mechanisms and extracellular concentrations. ” J neurochemistry 79(3):463–484. https://doi.org/10.1046/j.1471-4159.2001.00607.x</Citation>
        </Reference>
        <Reference>
          <Citation>Lopes LV, Cunha RA, Ribeiro JA (Dec. 1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. ” J Neurophysiol 82(6):3196–3203. https://doi.org/10.1152/jn.1999.82.6.3196</Citation>
        </Reference>
        <Reference>
          <Citation>Linden J “Adenosine in tissue protection and tissue regeneration.,”Molecular pharmacology, vol. 67, no. 5, pp.1385–1387, May 2005. https://doi.org/10.1124/mol.105.011783</Citation>
        </Reference>
        <Reference>
          <Citation>Augusto E et al (Jul. 2013) “Ecto-5’-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 33(28):11390–11399. https://doi.org/10.1523/JNEUROSCI.5817-12.2013</Citation>
        </Reference>
        <Reference>
          <Citation>Grković I, Mitrović N, Dragić M, Adžić M, Drakulić D, Nedeljković N (Mar. 2019) “Spatial Distribution and Expression of Ectonucleotidases in Rat Hippocampus After Removal of Ovaries and Estradiol Replacement. ” Mol Neurobiol 56(3):1933–1945. https://doi.org/10.1007/s12035-018-1217-3</Citation>
        </Reference>
        <Reference>
          <Citation>Langer D, Hammer K, Koszalka P, Schrader J, Robson S, Zimmermann H (Nov. 2008) Distribution of ectonucleotidases in the rodent brain revisited. ” Cell and tissue research 334(2):199–217. https://doi.org/10.1007/s00441-008-0681-x</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N et al (Sep. 2016) Regional and sex-related differences in modulating effects of female sex steroids on ecto-5’-nucleotidase expression in the rat cerebral cortex and hippocampus. ” Gen Comp Endocrinol 235:100–107. https://doi.org/10.1016/j.ygcen.2016.06.018</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N, Dragić M, Zarić M, Drakulić D, Nedeljković N, Grković I (2019) Estrogen receptors modulate ectonucleotidases activity in hippocampal synaptosomes of male rats. Neurosci Lett 712. https://doi.org/10.1016/j.neulet.2019.134474</Citation>
        </Reference>
        <Reference>
          <Citation>Rosemberg DB et al (2008) “Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain.,” Comparative biochemistry and physiology Part B, Biochemistry &amp; molecular biology, vol. 151, no. 1, pp. 96–101, https://doi.org/10.1016/j.cbpb.2008.06.001</Citation>
        </Reference>
        <Reference>
          <Citation>Dong H, Zu X, Zheng P, Zhang D (Mar. 2015) “A rapid enzymatic assay for high-throughput screening of adenosine-producing strains. ” Microb Biotechnol 8(2):230–238. https://doi.org/10.1111/1751-7915.12189</Citation>
        </Reference>
        <Reference>
          <Citation>Buchet R, Millán JL, Magne D (2013) “Multisystemic functions of alkaline phosphatases.,” Methods in molecular biology (Clifton, NJ), vol. 1053, pp. 27–51, https://doi.org/10.1007/978-1-62703-562-0_3</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N et al (Mar. 2017) “17β-Estradiol-Induced Synaptic Rearrangements Are Accompanied by Altered Ectonucleotidase Activities in Male Rat Hippocampal Synaptosomes. ” J Mol neuroscience: MN 61(3):412–422. https://doi.org/10.1007/s12031-016-0877-6</Citation>
        </Reference>
        <Reference>
          <Citation>Adzic M, Nedeljkovic N (2018) Unveiling the Role of Ecto-5’-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools. ” Front Pharmacol 9:153. https://doi.org/10.3389/fphar.2018.00153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2018.00153</ArticleId>
            <ArticleId IdType="pubmed">29545748</ArticleId>
            <ArticleId IdType="pmc">5837971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanojević I et al (Jun. 2011) “Ontogenetic profile of ecto-5’-nucleotidase in rat brain synaptic plasma membranes. ” Int J Dev neuroscience: official J Int Soc Dev Neurosci 29(4):397–403. https://doi.org/10.1016/j.ijdevneu.2011.03.003</Citation>
        </Reference>
        <Reference>
          <Citation>Fuchs JL (1991) “5’-Nucleotidase activity increases in aging rat brain. ” Neurobiol aging 12(5):523–530. https://doi.org/10.1016/0197-4580(91)90083-V</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0197-4580(91)90083-V</ArticleId>
            <ArticleId IdType="pubmed">1770988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nwafor DC, Brichacek AL, Ali A, Brown CM (May 2021) Tissue-Nonspecific Alkaline Phosphatase in Central Nervous System Health and Disease: A Focus on Brain Microvascular Endothelial Cells. ” Int J Mol Sci 22(10). https://doi.org/10.3390/ijms22105257</Citation>
        </Reference>
        <Reference>
          <Citation>Sánchez-Melgar A, Albasanz JL, Pallàs M, Martín M (Oct. 2020) Adenosine Metabolism in the Cerebral Cortex from Several Mice Models during Aging. ” Int J Mol Sci 21(19). https://doi.org/10.3390/ijms21197300</Citation>
        </Reference>
        <Reference>
          <Citation>Sengupta P (2013) “The Laboratory Rat: Relating Its Age With Human’s.,” International journal of preventive medicine, vol. 4, no. 6, pp. 624–630, Jun.</Citation>
        </Reference>
        <Reference>
          <Citation>Fonta C, Négyessy L, Renaud L, Barone P (2004) “Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission.,” Cerebral cortex (New York, NY: 1991), vol. 14, no. 6, pp. 595–609, Jun. https://doi.org/10.1093/cercor/bhh021</Citation>
        </Reference>
        <Reference>
          <Citation>Lavrnja I et al (Apr. 2015) Expression of a second ecto-5’-nucleotidase variant besides the usual protein in symptomatic phase of experimental autoimmune encephalomyelitis. ” J Mol neuroscience: MN 55(4):898–911. https://doi.org/10.1007/s12031-014-0445-x</Citation>
        </Reference>
        <Reference>
          <Citation>Dragić M, Mitrović N, Adžić M, Nedeljković N, Grković I (2021) “Microglial- and Astrocyte-Specific Expression of Purinergic Signaling Components and Inflammatory Mediators in the Rat Hippocampus During Trimethyltin-Induced Neurodegeneration. ” ASN neuro 13:17590914211044882. https://doi.org/10.1177/17590914211044882</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/17590914211044882</ArticleId>
            <ArticleId IdType="pubmed">34569324</ArticleId>
            <ArticleId IdType="pmc">8495514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dragić M et al (Jun. 2021) Downregulation of CD73/A(2A)R-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis. ” Brain sciences 11(6). https://doi.org/10.3390/brainsci11060736</Citation>
        </Reference>
        <Reference>
          <Citation>et al., “Brain endothelial cell tissue-nonspecific alkaline phosphatase (TNAP) activity promotes maintenance of barrier integrity via the ROCK pathway,”bioRxiv, p. 2021.03.25.437097, Jan. 2021. https://doi.org/10.1101/2021.03.25.437097</Citation>
        </Reference>
        <Reference>
          <Citation>Nwafor DC et al (2020) “Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis.,” Brain, behavior, and immunity, vol. 84, pp. 115–131, https://doi.org/10.1016/j.bbi.2019.11.016</Citation>
        </Reference>
        <Reference>
          <Citation>Zamanian JL et al (May 2012) Genomic analysis of reactive astrogliosis. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 32(18):6391–6410. https://doi.org/10.1523/JNEUROSCI.6221-11.2012</Citation>
        </Reference>
        <Reference>
          <Citation>Chen MB et al (2020) Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues. ” Cell reports 30(13):4418–4432. https://doi.org/10.1016/j.celrep.2020.03.012 . .e4, Mar</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Hernandez M, Hernandez F, Miras-Portugal MT, Avila J (2015) “TNAP Plays a Key Role in Neural Differentiation as well as in Neurodegenerative Disorders. ” Sub-cellular biochemistry 76:375–385. https://doi.org/10.1007/978-94-017-7197-9_18</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-94-017-7197-9_18</ArticleId>
            <ArticleId IdType="pubmed">26219721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Négyessy L et al (Jan. 2011) Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex. ” Neurosci 172:406–418. https://doi.org/10.1016/j.neuroscience.2010.10.049</Citation>
        </Reference>
        <Reference>
          <Citation>Brun-Heath I et al (Mar. 2011) “Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues. ” Cell and tissue research 343(3):521–536. https://doi.org/10.1007/s00441-010-1111-4</Citation>
        </Reference>
        <Reference>
          <Citation>Geiger JD, Nagy JI (Jan. 1987) Ontogenesis of adenosine deaminase activity in rat brain. ” J neurochemistry 48(1):147–153. https://doi.org/10.1111/j.1471-4159.1987.tb13139.x</Citation>
        </Reference>
        <Reference>
          <Citation>Flinn AM, Gennery AR (Apr. 2018) Adenosine deaminase deficiency: a review. ” Orphanet journal of rare diseases 13(1):65. https://doi.org/10.1186/s13023-018-0807-5</Citation>
        </Reference>
        <Reference>
          <Citation>Allen SP et al (Mar. 2019) Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. ” Brain: a journal of neurology 142(3):586–605. https://doi.org/10.1093/brain/awy353</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA, Johansson B, Fredholm BB, Ribeiro JA, Sebastião AM (Aug. 1995) Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. ” Neurosci Lett 196:1–2. https://doi.org/10.1016/0304-3940(95)11833-I</Citation>
        </Reference>
        <Reference>
          <Citation>Temido-Ferreira M et al (2020) “Age-related shift in LTD is dependent on neuronal adenosine A(2A) receptors interplay with mGluR5 and NMDA receptors.,” Molecular psychiatry, vol. 25, no. 8, pp. 1876–1900, https://doi.org/10.1038/s41380-018-0110-9</Citation>
        </Reference>
        <Reference>
          <Citation>Gomes CV, Kaster MP, Tomé AR, Agostinho PM, Cunha RA (May 2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. ” Biochim et Biophys acta 1808(5):1380–1399. https://doi.org/10.1016/j.bbamem.2010.12.001</Citation>
        </Reference>
        <Reference>
          <Citation>Pagnussat N et al (Aug. 2015) Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice. ” Br J Pharmacol 172:3831–3845. https://doi.org/10.1111/bph.13180</Citation>
        </Reference>
        <Reference>
          <Citation>Santiago AR et al (2014) “Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.,” Mediators of inflammation, vol. p. 465694, 2014. https://doi.org/10.1155/2014/465694</Citation>
        </Reference>
        <Reference>
          <Citation>Carvalho K et al (Nov. 2019) “Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. ” Brain: a journal of neurology 142(11):3636–3654. https://doi.org/10.1093/brain/awz288</Citation>
        </Reference>
        <Reference>
          <Citation>Nedeljkovic N (Jun. 2019) Complex regulation of ecto-5’-nucleotidase/CD73 and A(2A)R-mediated adenosine signaling at neurovascular unit: A link between acute and chronic neuroinflammation. ” Pharmacol Res 144:99–115. https://doi.org/10.1016/j.phrs.2019.04.007</Citation>
        </Reference>
        <Reference>
          <Citation>Borroto-Escuela DO, Hinz S, Navarro G, Franco R, Müller CE, Fuxe K (2018) Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation. ” Front Neurosci 12:43. https://doi.org/10.3389/fnins.2018.00043</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2018.00043</ArticleId>
            <ArticleId IdType="pubmed">29467608</ArticleId>
            <ArticleId IdType="pmc">5808169</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35320461</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-6903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurochemical research</Title>
          <ISOAbbreviation>Neurochem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Altered Topographic Distribution and Enhanced Neuronal Expression of Adenosine-Metabolizing Enzymes in Rat Hippocampus and Cortex from Early to late Adulthood.</ArticleTitle>
        <Pagination>
          <StartPage>1637</StartPage>
          <EndPage>1650</EndPage>
          <MedlinePgn>1637-1650</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-022-03557-5</ELocationID>
        <Abstract>
          <AbstractText>The present study demonstrates altered topographic distribution and enhanced neuronal expression of major adenosine-metabolizing enzymes, i.e. ecto-5'-nucleotidase (eN) and tissue non-specific alkaline phosphatase (TNAP), as well as adenosine receptor subtype A<sub>2A</sub> in the hippocampus and cortex of male rats from early to late adulthood (3, 6, 12 and 15 months old males). The significant effect of age was demonstrated for the increase in the activity and the protein expression of eN and TNAP. At 15-m, enzyme histochemistry demonstrated enhanced expression of eN in synapse-rich hippocampal and cortical layers, whereas the upsurge of TNAP was observed in the hippocampal and cortical neuropil, rather than in cells and layers where two enzymes mostly reside in 3-m old brain. Furthermore, a dichotomy in A<sub>1</sub>R and A<sub>2A</sub>R expression was demonstrated in the cortex and hippocampus from early to late adulthood. Specifically, a decrease in A<sub>1</sub>R and enhancement of A<sub>2A</sub>R expression were demonstrated by immunohistochemistry, the latter being almost exclusively localized in hippocampal pyramidal and cortical superficial cell layers. We did not observe any glial upregulation of A<sub>2A</sub>R, which was common for both advanced age and chronic neurodegeneration. Taken together, the results imply that the adaptative changes in adenosine signaling occurring in neuronal elements early in life may be responsible for the later prominent glial enhancement in A<sub>2A</sub>R-mediated adenosine signaling, and neuroinflammation and neurodegeneration, which are the hallmarks of both advanced age and age-associated neurodegenerative diseases.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dragic</LastName>
            <ForeName>Milorad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4855-6131</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stekic</LastName>
            <ForeName>Andjela</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2353-2937</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeljkovic</LastName>
            <ForeName>Milica</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5608-4384</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaric Kontic</LastName>
            <ForeName>Marina</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-1635-9766</Identifier>
            <AffiliationInfo>
              <Affiliation>Department for Molecular biology and Endocrinology, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mihajlovic</LastName>
            <ForeName>Katarina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adzic</LastName>
            <ForeName>Marija</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4018-0758</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grkovic</LastName>
            <ForeName>Ivana</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0003-4476-7871</Identifier>
            <AffiliationInfo>
              <Affiliation>Department for Molecular biology and Endocrinology, Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nedeljkovic</LastName>
            <ForeName>Nadezda</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-3046-0983</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Studentski trg 3, 11001, Belgrade, Serbia. nnedel@bio.bg.ac.rs.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurochem Res</MedlineTA>
        <NlmUniqueID>7613461</NlmUniqueID>
        <ISSNLinking>0364-3190</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043705">Receptor, Adenosine A2A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.5</RegistryNumber>
          <NameOfSubstance UI="D015720">5'-Nucleotidase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>K72T3FS567</RegistryNumber>
          <NameOfSubstance UI="D000241">Adenosine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015720" MajorTopicYN="Y">5'-Nucleotidase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000241" MajorTopicYN="Y">Adenosine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043705" MajorTopicYN="N">Receptor, Adenosine A2A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">A2AR</Keyword>
        <Keyword MajorTopicYN="N">Adenosine deaminase (ADA)</Keyword>
        <Keyword MajorTopicYN="N">Tissue non-specific alkaline phosphatase (TNAP)</Keyword>
        <Keyword MajorTopicYN="N">ecto-5ʹ-nucleotidase/CD73</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>17</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35320461</ArticleId>
        <ArticleId IdType="doi">10.1007/s11064-022-03557-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s11064-022-03557-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jin K (2010) “Modern Biological Theories of Aging.,” Aging and disease, vol. 1, no. 2, pp. 72–74, Oct.</Citation>
        </Reference>
        <Reference>
          <Citation>Mattson MP, Arumugam TV (Jun. 2018) “Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. ” Cell metabolism 27(6):1176–1199. https://doi.org/10.1016/j.cmet.2018.05.011</Citation>
        </Reference>
        <Reference>
          <Citation>Drayer BP (Mar. 1988) “Imaging of the aging brain. Part I. Normal findings. ” Radiol 166(3):785–796. https://doi.org/10.1148/radiology.166.3.3277247</Citation>
        </Reference>
        <Reference>
          <Citation>Deary IJ et al (2009) Age-associated cognitive decline. ” Br Med Bull 92:135–152. https://doi.org/10.1093/bmb/ldp033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bmb/ldp033</ArticleId>
            <ArticleId IdType="pubmed">19776035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimohama S et al (1998) “Differential expression of rat brain synaptic proteins in development and aging.,” Biochemical and biophysical research communications, vol. 251, no. 1, pp. 394–398, https://doi.org/10.1006/bbrc.1998.9480</Citation>
        </Reference>
        <Reference>
          <Citation>Pannese E (2011) “Morphological changes in nerve cells during normal aging.,” Brain structure &amp; function, vol. 216, no. 2, pp. 85–89, Jun. https://doi.org/10.1007/s00429-011-0308-y</Citation>
        </Reference>
        <Reference>
          <Citation>Boisvert MM, Erikson GA, Shokhirev MN, Allen NJ (Jan. 2018) The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain. ” Cell reports 22(1):269–285. https://doi.org/10.1016/j.celrep.2017.12.039</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA (Dec. 2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139(6):1019–1055. https://doi.org/10.1111/jnc.13724</Citation>
        </Reference>
        <Reference>
          <Citation>Kovács Z, Juhász G, Palkovits M, Dobolyi A, Kékesi KA (2011) “Area, age and gender dependence of the nucleoside system in the brain: a review of current literature. ” Curr Top Med Chem 11(8):1012–1033. https://doi.org/10.2174/156802611795347636</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156802611795347636</ArticleId>
            <ArticleId IdType="pubmed">21401498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fredholm BB, Chern Y, Franco R, Sitkovsky M (Dec. 2007) Aspects of the general biology of adenosine A2A signaling. ” Progress in neurobiology 83(5):263–276. https://doi.org/10.1016/j.pneurobio.2007.07.005</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA (Jan. 2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. ” Neurochemistry international 52:1–2. https://doi.org/10.1016/j.neuint.2007.06.026</Citation>
        </Reference>
        <Reference>
          <Citation>Pazzagli M, Corsi C, Fratti S, Pedata F, Pepeu G (Jun. 1995) Regulation of extracellular adenosine levels in the striatum of aging rats. ” Brain research 684(1):103–106. https://doi.org/10.1016/0006-8993(95)00471-2</Citation>
        </Reference>
        <Reference>
          <Citation>Rex CS, Kramár EA, Colgin LL, Lin B, Gall CM, Lynch G (2005) “Long-term potentiation is impaired in middle-aged rats: regional specificity and reversal by adenosine receptor antagonists.,” The Journal of neuroscience: the official journal of the Society for Neuroscience, vol. 25, no. 25, pp. 5956–5966, Jun. https://doi.org/10.1523/JNEUROSCI.0880-05.2005</Citation>
        </Reference>
        <Reference>
          <Citation>Mackiewicz M et al (Feb. 2006) Age-related changes in adenosine metabolic enzymes in sleep/wake regulatory areas of the brain. ” Neurobiol aging 27(2):351–360. https://doi.org/10.1016/j.neurobiolaging.2005.01.015</Citation>
        </Reference>
        <Reference>
          <Citation>Gharib A, Sarda N, Chabannes B, Cronenberger L, Pacheco H (Mar. 1982) “The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. ” J neurochemistry 38(3):810–815. https://doi.org/10.1111/j.1471-4159.1982.tb08702.x</Citation>
        </Reference>
        <Reference>
          <Citation>Murillo-Rodriguez E, Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ (2004) The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats. ” Neurosci 123(2):361–370. https://doi.org/10.1016/j.neuroscience.2003.09.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2003.09.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovács Z et al (Apr. 2010) “Gender- and age-dependent changes in nucleoside levels in the cerebral cortex and white matter of the human brain. ” Brain research bulletin 81(6):579–584. https://doi.org/10.1016/j.brainresbull.2009.10.010</Citation>
        </Reference>
        <Reference>
          <Citation>Chu S et al (Jan. 2013) Regulation of adenosine levels during cerebral ischemia. ” Acta pharmacologica Sinica 34(1):60–66. https://doi.org/10.1038/aps.2012.127</Citation>
        </Reference>
        <Reference>
          <Citation>Zimmermann H, Zebisch M, Sträter N (Sep. 2012) “Cellular function and molecular structure of ecto-nucleotidases. ” Purinergic signalling 8(3):437–502. https://doi.org/10.1007/s11302-012-9309-4</Citation>
        </Reference>
        <Reference>
          <Citation>Street SE et al (Jul. 2013) “Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 33:11314–11322. https://doi.org/10.1523/JNEUROSCI.0133-13.2013</Citation>
        </Reference>
        <Reference>
          <Citation>Latini S, Pedata F (Nov. 2001) “Adenosine in the central nervous system: release mechanisms and extracellular concentrations. ” J neurochemistry 79(3):463–484. https://doi.org/10.1046/j.1471-4159.2001.00607.x</Citation>
        </Reference>
        <Reference>
          <Citation>Lopes LV, Cunha RA, Ribeiro JA (Dec. 1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. ” J Neurophysiol 82(6):3196–3203. https://doi.org/10.1152/jn.1999.82.6.3196</Citation>
        </Reference>
        <Reference>
          <Citation>Linden J “Adenosine in tissue protection and tissue regeneration.,”Molecular pharmacology, vol. 67, no. 5, pp.1385–1387, May 2005. https://doi.org/10.1124/mol.105.011783</Citation>
        </Reference>
        <Reference>
          <Citation>Augusto E et al (Jul. 2013) “Ecto-5’-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 33(28):11390–11399. https://doi.org/10.1523/JNEUROSCI.5817-12.2013</Citation>
        </Reference>
        <Reference>
          <Citation>Grković I, Mitrović N, Dragić M, Adžić M, Drakulić D, Nedeljković N (Mar. 2019) “Spatial Distribution and Expression of Ectonucleotidases in Rat Hippocampus After Removal of Ovaries and Estradiol Replacement. ” Mol Neurobiol 56(3):1933–1945. https://doi.org/10.1007/s12035-018-1217-3</Citation>
        </Reference>
        <Reference>
          <Citation>Langer D, Hammer K, Koszalka P, Schrader J, Robson S, Zimmermann H (Nov. 2008) Distribution of ectonucleotidases in the rodent brain revisited. ” Cell and tissue research 334(2):199–217. https://doi.org/10.1007/s00441-008-0681-x</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N et al (Sep. 2016) Regional and sex-related differences in modulating effects of female sex steroids on ecto-5’-nucleotidase expression in the rat cerebral cortex and hippocampus. ” Gen Comp Endocrinol 235:100–107. https://doi.org/10.1016/j.ygcen.2016.06.018</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N, Dragić M, Zarić M, Drakulić D, Nedeljković N, Grković I (2019) Estrogen receptors modulate ectonucleotidases activity in hippocampal synaptosomes of male rats. Neurosci Lett 712. https://doi.org/10.1016/j.neulet.2019.134474</Citation>
        </Reference>
        <Reference>
          <Citation>Rosemberg DB et al (2008) “Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain.,” Comparative biochemistry and physiology Part B, Biochemistry &amp; molecular biology, vol. 151, no. 1, pp. 96–101, https://doi.org/10.1016/j.cbpb.2008.06.001</Citation>
        </Reference>
        <Reference>
          <Citation>Dong H, Zu X, Zheng P, Zhang D (Mar. 2015) “A rapid enzymatic assay for high-throughput screening of adenosine-producing strains. ” Microb Biotechnol 8(2):230–238. https://doi.org/10.1111/1751-7915.12189</Citation>
        </Reference>
        <Reference>
          <Citation>Buchet R, Millán JL, Magne D (2013) “Multisystemic functions of alkaline phosphatases.,” Methods in molecular biology (Clifton, NJ), vol. 1053, pp. 27–51, https://doi.org/10.1007/978-1-62703-562-0_3</Citation>
        </Reference>
        <Reference>
          <Citation>Mitrović N et al (Mar. 2017) “17β-Estradiol-Induced Synaptic Rearrangements Are Accompanied by Altered Ectonucleotidase Activities in Male Rat Hippocampal Synaptosomes. ” J Mol neuroscience: MN 61(3):412–422. https://doi.org/10.1007/s12031-016-0877-6</Citation>
        </Reference>
        <Reference>
          <Citation>Adzic M, Nedeljkovic N (2018) Unveiling the Role of Ecto-5’-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools. ” Front Pharmacol 9:153. https://doi.org/10.3389/fphar.2018.00153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2018.00153</ArticleId>
            <ArticleId IdType="pubmed">29545748</ArticleId>
            <ArticleId IdType="pmc">5837971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanojević I et al (Jun. 2011) “Ontogenetic profile of ecto-5’-nucleotidase in rat brain synaptic plasma membranes. ” Int J Dev neuroscience: official J Int Soc Dev Neurosci 29(4):397–403. https://doi.org/10.1016/j.ijdevneu.2011.03.003</Citation>
        </Reference>
        <Reference>
          <Citation>Fuchs JL (1991) “5’-Nucleotidase activity increases in aging rat brain. ” Neurobiol aging 12(5):523–530. https://doi.org/10.1016/0197-4580(91)90083-V</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0197-4580(91)90083-V</ArticleId>
            <ArticleId IdType="pubmed">1770988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nwafor DC, Brichacek AL, Ali A, Brown CM (May 2021) Tissue-Nonspecific Alkaline Phosphatase in Central Nervous System Health and Disease: A Focus on Brain Microvascular Endothelial Cells. ” Int J Mol Sci 22(10). https://doi.org/10.3390/ijms22105257</Citation>
        </Reference>
        <Reference>
          <Citation>Sánchez-Melgar A, Albasanz JL, Pallàs M, Martín M (Oct. 2020) Adenosine Metabolism in the Cerebral Cortex from Several Mice Models during Aging. ” Int J Mol Sci 21(19). https://doi.org/10.3390/ijms21197300</Citation>
        </Reference>
        <Reference>
          <Citation>Sengupta P (2013) “The Laboratory Rat: Relating Its Age With Human’s.,” International journal of preventive medicine, vol. 4, no. 6, pp. 624–630, Jun.</Citation>
        </Reference>
        <Reference>
          <Citation>Fonta C, Négyessy L, Renaud L, Barone P (2004) “Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission.,” Cerebral cortex (New York, NY: 1991), vol. 14, no. 6, pp. 595–609, Jun. https://doi.org/10.1093/cercor/bhh021</Citation>
        </Reference>
        <Reference>
          <Citation>Lavrnja I et al (Apr. 2015) Expression of a second ecto-5’-nucleotidase variant besides the usual protein in symptomatic phase of experimental autoimmune encephalomyelitis. ” J Mol neuroscience: MN 55(4):898–911. https://doi.org/10.1007/s12031-014-0445-x</Citation>
        </Reference>
        <Reference>
          <Citation>Dragić M, Mitrović N, Adžić M, Nedeljković N, Grković I (2021) “Microglial- and Astrocyte-Specific Expression of Purinergic Signaling Components and Inflammatory Mediators in the Rat Hippocampus During Trimethyltin-Induced Neurodegeneration. ” ASN neuro 13:17590914211044882. https://doi.org/10.1177/17590914211044882</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/17590914211044882</ArticleId>
            <ArticleId IdType="pubmed">34569324</ArticleId>
            <ArticleId IdType="pmc">8495514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dragić M et al (Jun. 2021) Downregulation of CD73/A(2A)R-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis. ” Brain sciences 11(6). https://doi.org/10.3390/brainsci11060736</Citation>
        </Reference>
        <Reference>
          <Citation>et al., “Brain endothelial cell tissue-nonspecific alkaline phosphatase (TNAP) activity promotes maintenance of barrier integrity via the ROCK pathway,”bioRxiv, p. 2021.03.25.437097, Jan. 2021. https://doi.org/10.1101/2021.03.25.437097</Citation>
        </Reference>
        <Reference>
          <Citation>Nwafor DC et al (2020) “Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis.,” Brain, behavior, and immunity, vol. 84, pp. 115–131, https://doi.org/10.1016/j.bbi.2019.11.016</Citation>
        </Reference>
        <Reference>
          <Citation>Zamanian JL et al (May 2012) Genomic analysis of reactive astrogliosis. ” The Journal of neuroscience: the official journal of the Society for Neuroscience 32(18):6391–6410. https://doi.org/10.1523/JNEUROSCI.6221-11.2012</Citation>
        </Reference>
        <Reference>
          <Citation>Chen MB et al (2020) Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues. ” Cell reports 30(13):4418–4432. https://doi.org/10.1016/j.celrep.2020.03.012 . .e4, Mar</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Hernandez M, Hernandez F, Miras-Portugal MT, Avila J (2015) “TNAP Plays a Key Role in Neural Differentiation as well as in Neurodegenerative Disorders. ” Sub-cellular biochemistry 76:375–385. https://doi.org/10.1007/978-94-017-7197-9_18</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-94-017-7197-9_18</ArticleId>
            <ArticleId IdType="pubmed">26219721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Négyessy L et al (Jan. 2011) Layer-specific activity of tissue non-specific alkaline phosphatase in the human neocortex. ” Neurosci 172:406–418. https://doi.org/10.1016/j.neuroscience.2010.10.049</Citation>
        </Reference>
        <Reference>
          <Citation>Brun-Heath I et al (Mar. 2011) “Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues. ” Cell and tissue research 343(3):521–536. https://doi.org/10.1007/s00441-010-1111-4</Citation>
        </Reference>
        <Reference>
          <Citation>Geiger JD, Nagy JI (Jan. 1987) Ontogenesis of adenosine deaminase activity in rat brain. ” J neurochemistry 48(1):147–153. https://doi.org/10.1111/j.1471-4159.1987.tb13139.x</Citation>
        </Reference>
        <Reference>
          <Citation>Flinn AM, Gennery AR (Apr. 2018) Adenosine deaminase deficiency: a review. ” Orphanet journal of rare diseases 13(1):65. https://doi.org/10.1186/s13023-018-0807-5</Citation>
        </Reference>
        <Reference>
          <Citation>Allen SP et al (Mar. 2019) Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. ” Brain: a journal of neurology 142(3):586–605. https://doi.org/10.1093/brain/awy353</Citation>
        </Reference>
        <Reference>
          <Citation>Cunha RA, Johansson B, Fredholm BB, Ribeiro JA, Sebastião AM (Aug. 1995) Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus. ” Neurosci Lett 196:1–2. https://doi.org/10.1016/0304-3940(95)11833-I</Citation>
        </Reference>
        <Reference>
          <Citation>Temido-Ferreira M et al (2020) “Age-related shift in LTD is dependent on neuronal adenosine A(2A) receptors interplay with mGluR5 and NMDA receptors.,” Molecular psychiatry, vol. 25, no. 8, pp. 1876–1900, https://doi.org/10.1038/s41380-018-0110-9</Citation>
        </Reference>
        <Reference>
          <Citation>Gomes CV, Kaster MP, Tomé AR, Agostinho PM, Cunha RA (May 2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. ” Biochim et Biophys acta 1808(5):1380–1399. https://doi.org/10.1016/j.bbamem.2010.12.001</Citation>
        </Reference>
        <Reference>
          <Citation>Pagnussat N et al (Aug. 2015) Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice. ” Br J Pharmacol 172:3831–3845. https://doi.org/10.1111/bph.13180</Citation>
        </Reference>
        <Reference>
          <Citation>Santiago AR et al (2014) “Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.,” Mediators of inflammation, vol. p. 465694, 2014. https://doi.org/10.1155/2014/465694</Citation>
        </Reference>
        <Reference>
          <Citation>Carvalho K et al (Nov. 2019) “Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. ” Brain: a journal of neurology 142(11):3636–3654. https://doi.org/10.1093/brain/awz288</Citation>
        </Reference>
        <Reference>
          <Citation>Nedeljkovic N (Jun. 2019) Complex regulation of ecto-5’-nucleotidase/CD73 and A(2A)R-mediated adenosine signaling at neurovascular unit: A link between acute and chronic neuroinflammation. ” Pharmacol Res 144:99–115. https://doi.org/10.1016/j.phrs.2019.04.007</Citation>
        </Reference>
        <Reference>
          <Citation>Borroto-Escuela DO, Hinz S, Navarro G, Franco R, Müller CE, Fuxe K (2018) Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation. ” Front Neurosci 12:43. https://doi.org/10.3389/fnins.2018.00043</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2018.00043</ArticleId>
            <ArticleId IdType="pubmed">29467608</ArticleId>
            <ArticleId IdType="pmc">5808169</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
